{"symbol":"BSX","fiscalQuarter":"Q4-2012","reportDate":"2013-01-29","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2012","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Up 3.5%","keyNumbers":[{"metric":"EPS","actual":"$0.18","expected":"N/A","surprise":"+65.14%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key product areas.","They expressed confidence in future growth despite not providing specific guidance."],"summary":"Overall, management conveyed a positive outlook on the company's performance. They emphasized their commitment to innovation and market expansion."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's strong EPS performance, exceeding expectations significantly, led to a 3.5% increase in stock price. Investors reacted positively to the company's ability to outperform on earnings, even without revenue figures or specific guidance. The management's optimistic tone suggests confidence in future growth, which may further bolster investor sentiment.","metaDescription":"Boston Scientific (BSX) Q4 2012 earnings: EPS beat expectations. Stock up 3.5%. Full breakdown."}}